Article
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery.
Antiviral research - 1 Dec 2010
Rhee Soo-Yon, Margeridon-Thermet Severine, Nguyen Mindie H, Liu Tommy F, Kagan Ron M, Beggel Bastian, Verheyen Jens, Kaiser Rolf, Shafer Robert W
Abstract excerpt
Drug resistance resulting from reverse transcriptase (RT) mutations is one of the main obstacles to successful hepatitis B virus (HBV) therapy. Indeed, HBV treatment guidelines recommend HBV genotypic resistance testing for patients receiving nucleos(t)ide RT inhibitors (N(t)RTIs) who develop virological failure. N(t)RTI-resistance mutations at 10 RT positions have been well characterized in phenotypic studies,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
